• Veeva, Sarah Cannon Research Institute Collaboration, City of Hope Receives Grant, More

    Jun 24 | Clinical Research News | Veeva and Sarah Cannon Research Institute has entered a strategic collaboration; City of Hope was awarded an up to $23.7 million contract from the Advanced Research Projects Agency for Health within the US Department of Health and Human Services; and more. More

  • Beyond Vitals: How Patient-Generated Data is Driving AI’s Healthcare Transformation

    Jun 20 | Clinical Research News | In recent years, AI in healthcare has attracted growing interest and investment, with new roles like Chief AI Officer and AI-specific policies underscoring its transformative potential. However, one critical factor is often overlooked: the quality of the data used to train AI algorithms. While AI’s impact is undeniable, its effectiveness depends on the depth, diversity, and granularity of the data it processes. More

  • Genetic Testing Transforms Medication Prescribing for Better Patient Outcomes

    Jun 18 | Clinical Research News | The UK National Health Service’s PROGRESS trial has achieved remarkable clinical success, with one in four patients having their prescriptions adjusted based on genetic test results, leading to safer and more effective treatments. The PROGRESS trial’s interim results reveal that 95% of the 500 patients tested carried genetic variants that directly influence how they metabolize common medications. More

  • AI Agent Speeds Up Trials with Instant, Personalized Participant Interactions

    Jun 17 | Clinical Research News | An artificial intelligence (AI) agent known as Grace is bringing clinical trials some much-needed speed and cost reduction and delivering more personalized, on-demand digital experiences for participants. Developed by fast-growing Grove AI, Grace has over the past year powered more than 50 phase 2 and 3 trials involving over 500,000 interactions with would-be and enrolled trial participants. More

  • IQVIA, NVIDIA Build AI Agents for Clinical Research

    Jun 11 | Clinical Research News | Today, IQVIA announced multiple AI orchestrator agents in collaboration with NVIDIA. These specialized agentic systems—covering trial start-up, target identification, clinical data review, and more—are designed to manage and accelerate drug development workflows for IQVIA customers. More

  • Clinical Research Reveals Third Castleman Disease Subtype After 45 Years

    Jun 10 | Clinical Research News | Researchers have made a landmark discovery in rare disease clinical research by identifying a new subtype of Castleman disease, marking the first major advancement in disease classification since the 1970s. The breakthrough demonstrates how patient-driven research registries can overcome traditional barriers in rare disease studies to generate clinically meaningful insights. More

  • Bridging the Gap Between GI Research and Routine Practice

    Jun 06 | Clinical Research News | Gastroenterology is seeing meaningful progress in clinical research. New therapies for inflammatory bowel disease, colorectal cancer, and metabolic dysfunction-associated steatohepatitis (MASH) are being developed with increasing speed and precision. Yet for many community-based practices, participating in that research remains a significant challenge. More

  • Smart Bandage Technology Advances from Animal Models to Human Clinical Testing

    Jun 04 | Clinical Research News | California Institute of Technology researchers have successfully transitioned their innovative "smart bandage" technology from preclinical animal studies to human clinical testing, marking a significant milestone in the development of real-time wound monitoring systems for chronic wound management. More

  • Many Approaches Collectively Aim at a Cure for Myeloma

    Jun 03 | Clinical Research News | A small not-for-profit organization has set itself up as a model for turning the nitty-gritty of scientific research into a metaphorical “black swan event” with major impact on the lives of patients living with an incurable disease. The overarching strategy of the International Myeloma Foundation (IMF) is to function as the convener of the broader myeloma community in ways that lead to improved outcomes for patients in terms of both their quality and quantity of life. More

  • Follow the Money: PhaseV’s AI for Holistic Solutions, Carta’s AI Platform Transforms Clinical Data, More

    May 30 | Clinical Research News | PhaseV intends to grow its vertical AI platform to provide holistic solutions for clinical development; Carta Healthcare is expanding to meet the surging demands among health systems and life sciences organizations for AI-driven innovation that can transform clinical data into valuable insights; and more. More
View more articles
 
DXX-Industry-spotlight
SOT

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

Read More